Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A. Olsen, Eric C. Vonderheid, Sean Whittaker et al.|Journal of Clinical Oncology|2011Cited by 657
Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomasEric C. Vonderheid, Rein Willemze, Maria Grazia Bernengo et al.|Journal of the American Academy of Dermatology|2002Cited by 493
Cytotoxic/natural killer cell cutaneous lymphomasMarco Santucci, Emilio Berti, Nicola Pimpinelli et al.|Cancer|2003Cited by 273
Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous LymphomasPier Luigi Zinzani, Maria Grazia Bernengo, Stefano Pileri et al.|Journal of Clinical Oncology|2006Cited by 230
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort studyPietro Quaglino, Maria Grazia Bernengo, Federica Marenco et al.|Annals of Oncology|2009Cited by 186